[{"study_name":"A Pilot Trial of Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in HLA Allo-Immunized Patients","study":"DIR","study_phs_number":"phs003212","study_url":"https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs003212.v1.p1","form_group":[{"form_group":"All forms within the study","form":[{"form":"demographic","form_description":"Form description not provided","form_name":"demographic","variable_group":[{"variable_group_name":"All variables","variable_group_description":"All variables within the form","variable":[{"variable_id":"SUBJECT_ID","variable_name":"Subject ID","Variable Type":"string","variable_description":"Subject ID","data_hierarchy":"DIR-Eculizumab_GRU/demographic/Subject ID","derived_variable_level_data":[{"Variable Type":"string"}]},{"variable_id":"SEX","variable_name":"Sex","Variable Type":"string","variable_description":"Sex","data_hierarchy":"DIR-Eculizumab_GRU/demographic/Sex","derived_variable_level_data":[{"Variable Type":"string"}]},{"variable_id":"RACE","variable_name":"Race","Variable Type":"string","variable_description":"Race","data_hierarchy":"DIR-Eculizumab_GRU/demographic/Race","derived_variable_level_data":[{"Variable Type":"string"}]},{"variable_id":"ETHNICITY","variable_name":"Ethnicity","Variable Type":"string","variable_description":"Ethnicity","data_hierarchy":"DIR-Eculizumab_GRU/demographic/Ethnicity","derived_variable_level_data":[{"Variable Type":"string"}]},{"variable_id":"AGE_AT_ENROLLMENT","variable_name":"Age_at_enrollment","Variable Type":"numeric","variable_description":"Age_at_enrollment","data_hierarchy":"DIR-Eculizumab_GRU/demographic/Age_at_enrollment","derived_variable_level_data":[{"Variable Type":"numeric"}]},{"variable_id":"DIAGNOSIS","variable_name":"Diagnosis","Variable Type":"numeric","variable_description":"Diagnosis","data_hierarchy":"DIR-Eculizumab_GRU/demographic/Diagnosis","derived_variable_level_data":[{"Variable Type":"numeric"}]},{"variable_id":"BSA","variable_name":"Body surface area (m^2)","Variable Type":"numeric","variable_description":"Body surface area (m^2)","data_hierarchy":"DIR-Eculizumab_GRU/demographic/Body surface area (m^2)","derived_variable_level_data":[{"Variable Type":"numeric"}]}]}]},{"form":"Outcome","form_description":"Form description not provided","form_name":"Outcome","variable_group":[{"variable_group_name":"All variables","variable_group_description":"All variables within the form","variable":[{"variable_id":"SUBJECT_ID","variable_name":"Subject ID","Variable Type":"string","variable_description":"Subject ID","data_hierarchy":"DIR-Eculizumab_GRU/Outcome/Subject ID","derived_variable_level_data":[{"Variable Type":"string"}]},{"variable_id":"PRECH50","variable_name":"CH50 (10^3 U/L) pre-eculizumab","Variable Type":"numeric","variable_description":"CH50 (10^3 U/L) pre-eculizumab","data_hierarchy":"DIR-Eculizumab_GRU/Outcome/CH50 (10^3 U-L) pre-eculizumab","derived_variable_level_data":[{"Variable Type":"numeric"}]},{"variable_id":"POSTCH50","variable_name":"CH50 (10^3 U/L) after-eculizumab","Variable Type":"string","variable_description":"CH50 (10^3 U/L) after-eculizumab","data_hierarchy":"DIR-Eculizumab_GRU/Outcome/CH50 (10^3 U-L) after-eculizumab","derived_variable_level_data":[{"Variable Type":"string"}]},{"variable_id":"NO_TRANSFUSION_PRE","variable_name":"Number of platelet transfusions within 2 weeks pre-eculizumab","Variable Type":"numeric","variable_description":"Number of platelet transfusions within 2 weeks pre-eculizumab","data_hierarchy":"DIR-Eculizumab_GRU/Outcome/Number of platelet transfusions within 2 weeks pre-eculizumab","derived_variable_level_data":[{"Variable Type":"numeric"}]},{"variable_id":"NO_TRANSFUSION_POST","variable_name":"Number of platelet transfusions within 2 weeks post-eculizumab","Variable Type":"numeric","variable_description":"Number of platelet transfusions within 2 weeks post-eculizumab","data_hierarchy":"DIR-Eculizumab_GRU/Outcome/Number of platelet transfusions within 2 weeks post-eculizumab","derived_variable_level_data":[{"Variable Type":"numeric"}]}]}]},{"form":"Platelet","form_description":"Form description not provided","form_name":"Platelet","variable_group":[{"variable_group_name":"All variables","variable_group_description":"All variables within the form","variable":[{"variable_id":"SUBJECT_ID","variable_name":"Subject ID","Variable Type":"string","variable_description":"Subject ID","data_hierarchy":"DIR-Eculizumab_GRU/Platelet/Subject ID","derived_variable_level_data":[{"Variable Type":"string"}]},{"variable_id":"DAYS_ON_STUDY","variable_name":"Days on study (time 0= time of eculizumab administration)","Variable Type":"numeric","variable_description":"Days on study (time 0= time of eculizumab administration)","data_hierarchy":"DIR-Eculizumab_GRU/Platelet/Days on study (time 0= time of eculizumab administration)","derived_variable_level_data":[{"Variable Type":"numeric"}]},{"variable_id":"PLT COUNT","variable_name":"platelet count (x10^9/L)","Variable Type":"numeric","variable_description":"platelet count (x10^9/L)","data_hierarchy":"DIR-Eculizumab_GRU/Platelet/platelet count (x10^9-L)","derived_variable_level_data":[{"Variable Type":"numeric"}]}]}]},{"form":"Response","form_description":"Form description not provided","form_name":"Response","variable_group":[{"variable_group_name":"All variables","variable_group_description":"All variables within the form","variable":[{"variable_id":"SUBJECT_ID","variable_name":"Subject ID","Variable Type":"string","variable_description":"Subject ID","data_hierarchy":"DIR-Eculizumab_GRU/Response/Subject ID","derived_variable_level_data":[{"Variable Type":"string"}]},{"variable_id":"PREA1","variable_name":"#1 CCI 1h pre-eculizumab","Variable Type":"numeric","variable_description":"#1 CCI 1h pre-eculizumab","data_hierarchy":"DIR-Eculizumab_GRU/Response/#1 CCI 1h pre-eculizumab","derived_variable_level_data":[{"Variable Type":"numeric"}]},{"variable_id":"PREB1","variable_name":"#2 CCI 1h pre-eculizumab","Variable Type":"numeric","variable_description":"#2 CCI 1h pre-eculizumab","data_hierarchy":"DIR-Eculizumab_GRU/Response/#2 CCI 1h pre-eculizumab","derived_variable_level_data":[{"Variable Type":"numeric"}]},{"variable_id":"POSTA1","variable_name":"#1 CCI 1h post-eculizumab","Variable Type":"numeric","variable_description":"#1 CCI 1h post-eculizumab","data_hierarchy":"DIR-Eculizumab_GRU/Response/#1 CCI 1h post-eculizumab","derived_variable_level_data":[{"Variable Type":"numeric"}]},{"variable_id":"POSTA24","variable_name":"#1 CCI 18-24h post-eculizumab","Variable Type":"numeric","variable_description":"#1 CCI 18-24h post-eculizumab","data_hierarchy":"DIR-Eculizumab_GRU/Response/#1 CCI 18-24h post-eculizumab","derived_variable_level_data":[{"Variable Type":"numeric"}]},{"variable_id":"POSTB1","variable_name":"#2 CCI 1h post-eculizumab","Variable Type":"numeric","variable_description":"#2 CCI 1h post-eculizumab","data_hierarchy":"DIR-Eculizumab_GRU/Response/#2 CCI 1h post-eculizumab","derived_variable_level_data":[{"Variable Type":"numeric"}]},{"variable_id":"POSTB24","variable_name":"#2 CCI 18-24h post-eculizumab","Variable Type":"numeric","variable_description":"#2 CCI 18-24h post-eculizumab","data_hierarchy":"DIR-Eculizumab_GRU/Response/#2 CCI 18-24h post-eculizumab","derived_variable_level_data":[{"Variable Type":"numeric"}]},{"variable_id":"PRE1PLT","variable_name":"#1 platelet product  pre-eculizumab","Variable Type":"string","variable_description":"#1 platelet product  pre-eculizumab","data_hierarchy":"DIR-Eculizumab_GRU/Response/#1 platelet product  pre-eculizumab","derived_variable_level_data":[{"Variable Type":"string"}]},{"variable_id":"PRE2PLT","variable_name":"#2 platelet product  pre-eculizumab","Variable Type":"string","variable_description":"#2 platelet product  pre-eculizumab","data_hierarchy":"DIR-Eculizumab_GRU/Response/#2 platelet product  pre-eculizumab","derived_variable_level_data":[{"Variable Type":"string"}]},{"variable_id":"POST1PLT","variable_name":"#1 platelet product  post-eculizumab","Variable Type":"string","variable_description":"#1 platelet product  post-eculizumab","data_hierarchy":"DIR-Eculizumab_GRU/Response/#1 platelet product  post-eculizumab","derived_variable_level_data":[{"Variable Type":"string"}]},{"variable_id":"POST2PLT","variable_name":"#2 platelet product  post-eculizumab","Variable Type":"string","variable_description":"#2 platelet product  post-eculizumab","data_hierarchy":"DIR-Eculizumab_GRU/Response/#2 platelet product  post-eculizumab","derived_variable_level_data":[{"Variable Type":"string"}]}]}]}]}]}]
